Search Results for: Diabetes

3097 interactions found:

Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
CDKN2A and SERTAD1 cyclin-dependent kinase inhibitor 2A SERTA domain containing 1
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and MYL12A cyclin-dependent kinase inhibitor 2A myosin, light chain 12A, regulatory, non-sarcomeric
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Ephrin signaling
  • Axon guidance
  • EPH-Ephrin signaling
CDKN2A and DEAF1 cyclin-dependent kinase inhibitor 2A DEAF1 transcription factor
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and KAT5 cyclin-dependent kinase inhibitor 2A K(lysine) acetyltransferase 5
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Chromatin modifying enzymes
  • Chromatin organization
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • TCF dependent signaling in response to WNT
  • RNF mutants show enhanced WNT signaling and proliferation
  • formation of the beta-catenin:TCF transactivating complex
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • Signaling by Wnt
  • Signaling by WNT in cancer
  • HATs acetylate histones
CDKN2A and FN1 cyclin-dependent kinase inhibitor 2A fibronectin 1
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Elastic fibre formation
  • p130Cas linkage to MAPK signaling for integrins
  • Integrin alphaIIb beta3 signaling
  • GRB2:SOS provides linkage to MAPK signaling for Integrins
  • Non-integrin membrane-ECM interactions
  • Platelet degranulation
  • Platelet Aggregation (Plug Formation)
  • Degradation of the extracellular matrix
  • Cell surface interactions at the vascular wall
  • Molecules associated with elastic fibres
  • Syndecan interactions
  • ECM proteoglycans
  • Fibronectin matrix formation
  • Response to elevated platelet cytosolic Ca2+
  • Integrin cell surface interactions
  • Platelet activation, signaling and aggregation
  • Ocriplasmin
CDKN2A and PDCD6 cyclin-dependent kinase inhibitor 2A programmed cell death 6
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and CDKN2AIP cyclin-dependent kinase inhibitor 2A CDKN2A interacting protein
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and TUBA1C cyclin-dependent kinase inhibitor 2A tubulin, alpha 1c
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Transport of connexons to the plasma membrane
  • Mitotic Prometaphase
  • Organelle biogenesis and maintenance
  • Axon guidance
  • Hedgehog 'off' state
  • Separation of Sister Chromatids
  • Translocation of GLUT4 to the plasma membrane
  • G2/M Transition
  • L1CAM interactions
  • Mitotic Anaphase
  • Recycling pathway of L1
  • Recruitment of NuMA to mitotic centrosomes
  • Formation of tubulin folding intermediates by CCT/TriC
  • Intraflagellar transport
  • M Phase
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding
  • Post-chaperonin tubulin folding pathway
  • Gap junction trafficking and regulation
  • MHC class II antigen presentation
  • Recruitment of mitotic centrosome proteins and complexes
  • Protein folding
  • Gap junction assembly
  • Gap junction trafficking
  • Kinesins
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Assembly of the primary cilium
  • Factors involved in megakaryocyte development and platelet production
  • Cell Cycle, Mitotic
  • Resolution of Sister Chromatid Cohesion
  • Chaperonin-mediated protein folding
  • Signaling by Hedgehog
  • Centrosome maturation
  • Mitotic G2-G2/M phases
  • Mitotic Metaphase and Anaphase
  • Adaptive Immune System
  • Epothilone D
  • Epothilone B
  • 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
CDKN2A and HIST3H2BB cyclin-dependent kinase inhibitor 2A histone cluster 3, H2bb
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • RNA Polymerase I Chain Elongation
  • RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription
  • Mitotic Prophase
  • Regulatory RNA pathways
  • RNA Polymerase I Promoter Clearance
  • Deposition of new CENPA-containing nucleosomes at the centromere
  • Cellular Senescence
  • Signaling by Wnt
  • HATs acetylate histones
  • M Phase
  • Amyloids
  • NoRC negatively regulates rRNA expression
  • Packaging Of Telomere Ends
  • Telomere Maintenance
  • Nucleosome assembly
  • RNF mutants show enhanced WNT signaling and proliferation
  • XAV939 inhibits tankyrase, stabilizing AXIN
  • DNA methylation
  • Transcriptional regulation by small RNAs
  • Meiotic recombination
  • DNA Damage/Telomere Stress Induced Senescence
  • Chromosome Maintenance
  • Chromatin organization
  • HDACs deacetylate histones
  • misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling
  • RNA Polymerase I Transcription
  • formation of the beta-catenin:TCF transactivating complex
  • Meiotic synapsis
  • Epigenetic regulation of gene expression
  • Senescence-Associated Secretory Phenotype (SASP)
  • Negative epigenetic regulation of rRNA expression
  • PRC2 methylates histones and DNA
  • Cell Cycle, Mitotic
  • Chromatin modifying enzymes
  • Oxidative Stress Induced Senescence
  • TCF dependent signaling in response to WNT
  • RNA Polymerase I Promoter Opening
  • SIRT1 negatively regulates rRNA Expression
  • Signaling by WNT in cancer
  • Condensation of Prophase Chromosomes
CDKN2A and MAPK8 cyclin-dependent kinase inhibitor 2A mitogen-activated protein kinase 8
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Toll Like Receptor 7/8 (TLR7/8) Cascade
  • Cellular Senescence
  • Activation of BH3-only proteins
  • FCERI mediated MAPK activation
  • Toll Like Receptor TLR6:TLR2 Cascade
  • Activation of BMF and translocation to mitochondria
  • Activated TLR4 signalling
  • Toll Like Receptor TLR1:TLR2 Cascade
  • Activation of the AP-1 family of transcription factors
  • MyD88 cascade initiated on plasma membrane
  • Toll Like Receptor 5 (TLR5) Cascade
  • Programmed Cell Death
  • MyD88 dependent cascade initiated on endosome
  • TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation
  • MyD88:Mal cascade initiated on plasma membrane
  • Toll Like Receptor 9 (TLR9) Cascade
  • Intrinsic Pathway for Apoptosis
  • JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1
  • Innate Immune System
  • Signalling by NGF
  • Cell death signalling via NRAGE, NRIF and NADE
  • TRIF-mediated TLR3/TLR4 signaling
  • MAP kinase activation in TLR cascade
  • p75 NTR receptor-mediated signalling
  • MyD88-independent cascade
  • Toll Like Receptor 2 (TLR2) Cascade
  • Toll-Like Receptors Cascades
  • Toll Like Receptor 10 (TLR10) Cascade
  • DSCAM interactions
  • NRIF signals cell death from the nucleus
  • Oxidative Stress Induced Senescence
  • Activation of BIM and translocation to mitochondria
  • Toll Like Receptor 3 (TLR3) Cascade
  • Toll Like Receptor 4 (TLR4) Cascade
  • NRAGE signals death through JNK
  • Fc epsilon receptor (FCERI) signaling
  • MAPK targets/ Nuclear events mediated by MAP kinases
CDKN2A and TUBB cyclin-dependent kinase inhibitor 2A tubulin, beta class I
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Organelle biogenesis and maintenance
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Loss of Nlp from mitotic centrosomes
  • G2/M Transition
  • Assembly of the primary cilium
  • Centrosome maturation
  • Regulation of PLK1 Activity at G2/M Transition
  • Mitotic G2-G2/M phases
  • Anchoring of the basal body to the plasma membrane
  • Recruitment of mitotic centrosome proteins and complexes
  • Cell Cycle, Mitotic
  • Vinorelbine
  • Vincristine
  • Vinblastine
  • Podofilox
  • Colchicine
  • Epothilone D
  • Epothilone B
CDKN2A and WRN cyclin-dependent kinase inhibitor 2A Werner syndrome, RecQ helicase-like
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and CRELD2 cyclin-dependent kinase inhibitor 2A cysteine-rich with EGF-like domains 2
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and SIVA1 cyclin-dependent kinase inhibitor 2A SIVA1, apoptosis-inducing factor
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and E2F1 cyclin-dependent kinase inhibitor 2A E2F transcription factor 1
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Cellular Senescence
  • Activation of BH3-only proteins
  • Oncogene Induced Senescence
  • Assembly of the pre-replicative complex
  • Pre-NOTCH Transcription and Translation
  • G2 Phase
  • G1/S Transition
  • G1/S-Specific Transcription
  • Programmed Cell Death
  • Pre-NOTCH Expression and Processing
  • Mitotic G1-G1/S phases
  • Intrinsic Pathway for Apoptosis
  • E2F mediated regulation of DNA replication
  • Signaling by NOTCH
  • DNA Replication Pre-Initiation
  • G1 Phase
  • M/G1 Transition
  • Regulation of DNA replication
  • G0 and Early G1
  • CDC6 association with the ORC:origin complex
  • Cell Cycle, Mitotic
  • Activation of NOXA and translocation to mitochondria
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • Activation of PUMA and translocation to mitochondria
  • Association of licensing factors with the pre-replicative complex
  • Mitotic G2-G2/M phases
  • Inhibition of replication initiation of damaged DNA by RB1/E2F1
CDKN2A and SNRPA cyclin-dependent kinase inhibitor 2A small nuclear ribonucleoprotein polypeptide A
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Processing of Capped Intron-Containing Pre-mRNA
  • mRNA Splicing
  • mRNA Splicing - Major Pathway
CDKN2A and E4F1 cyclin-dependent kinase inhibitor 2A E4F transcription factor 1
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and HUWE1 cyclin-dependent kinase inhibitor 2A HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Class I MHC mediated antigen processing & presentation
  • Adaptive Immune System
CDKN2A and YY1 cyclin-dependent kinase inhibitor 2A YY1 transcription factor
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
CDKN2A and GMNN cyclin-dependent kinase inhibitor 2A geminin, DNA replication inhibitor
  • Cyclin D associated events in G1
  • Oxidative Stress Induced Senescence
  • G1 Phase
  • Cellular Senescence
  • Senescence-Associated Secretory Phenotype (SASP)
  • Oncogene Induced Senescence
  • Mitotic G1-G1/S phases
  • Cell Cycle, Mitotic
  • Oxidative Stress Induced Senescence
  • Cellular Senescence
  • Oncogene Induced Senescence
  • DNA Replication Pre-Initiation
  • M/G1 Transition
  • Regulation of DNA replication
  • Removal of licensing factors from origins
  • CDT1 association with the CDC6:ORC:origin complex
  • Association of licensing factors with the pre-replicative complex
  • Cell Cycle, Mitotic
  • Assembly of the pre-replicative complex

Page 7 out of 155 pages